MMP7 and mesothelioma: Moreover, all uterine carcinosarcoma (UCS), ESCA, mesothelioma (MESO), and KIRC cases with genetic alterations had amplification of MMP7, with frequencies around 4%, 3%, 1%, and < 1%, respectively (Figure 4A).